A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
Clinical trial NCT00682279 · WITHDRAWN
Trial details
- NCT number
- NCT00682279
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.